Central diabetes insipidus and pain medications – a risky combination

BACKGROUND: Central Diabetes Insipidus (CDI) results from decreased production of antidiuretic hormone (ADH) leading to an inability to concentrate urine. CDI is treated with desmopressin (DDAVP). Rarely reported in the literature, opioids and non-steroidal anti-inflammatories (NSAIDs) can induce hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Teresa E., Mokashi, Arati, Cummings, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207735/
https://www.ncbi.nlm.nih.gov/pubmed/34134784
http://dx.doi.org/10.1186/s40842-021-00124-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207735/
https://www.ncbi.nlm.nih.gov/pubmed/34134784
http://dx.doi.org/10.1186/s40842-021-00124-9

Ejemplares similares